CRDF Operating Cash Flow (Statement)

Cardiff Oncology Inc · Operating Cash Flow (Statement)

CRDF logo

CRDF Operating Cash Flow (Statement)

Latest reported-$40.85M
CRDF TTM Cash from Operations (-$6.73M → -$40.85M)
High-resolution chart · PNG

CRDF operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cardiff Oncology Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-40,854,000
-37,416,999
-37,922,999
-42,222,999
-41,844,999
-42,747,000
-37,693,000
-34,565,000
-32,066,000
-29,968,000
-30,887,000
-33,138,000
-32,667,000
-32,230,000
-33,820,000
-31,820,000
-29,799,000
-27,405,000
-23,040,000
-20,773,937
-18,834,175
-18,824,325
-16,314,325
-14,467,252
-14,129,491
-13,281,341
-13,267,341
-13,603,257
-13,895,259
-13,702,866
-13,199,013
-12,917,648
-16,032,487
-17,379,006
-23,281,067
-28,954,509
-29,401,761
-32,882,356
-31,039,855
-28,843,934
-26,935,034
-24,301,850
-22,119,025
-19,176,960
-17,452,659
-14,661,596
-12,727,385
-10,715,282
-9,404,768
-8,487,259
-7,317,248
-6,778,000
-6,097,686
-5,658,233
-4,934,661
-4,139,735
-3,115,009
-2,266,736
-1,930,301
-1,809,707
-2,066,892
-2,658,653
-2,087,994
-1,685,988
-2,373,464
999,402
-22,459
-4,985,055
-4,399,446
-6,732,370
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.